Autolomous
PrivateLast Round
Grant
Jun 12, 2023
Total Funding Raised
$2.13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Autolomous is a software company that provides a digital manufacturing management platform for cell and gene therapy developers and manufacturers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management, Workflow Automation, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Autolomous Comparables
Compare Autolomous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TrakCel | 86% | |
| Leucine | 78% | |
| Apprentice | 78% |
Autolomous Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2023 | ||||
| Early Funding | Dec 27, 2022 | ||||
| Grant | Jul 27, 2021 | ||||
| Debt | May 4, 2021 | ||||
| Seed | Aug 5, 2020 |
Key People
Founding team and executive leadership
Autolomous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UKRI Innovate UK | Debt, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Grew 18% QoQ, from 34 to 40 employees.
- May 14, 2026
Monthly visitors increased 86% MoM, reaching 4K.
Recent news
Latest coverage and updates
- integrates_withJul 8, 2026
Autolomous integrated with Cellular Origins Ltd on Jul 8th '26.
Autolomous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Autolomous's valuation, stock price, and market status.
Is Autolomous a public or private company?
Autolomous is a private company.
What is the current stock price of Autolomous?
Autolomous is a private company with no public stock price. No recent secondary market data is available.
How much is Autolomous worth (valuation)?
Valuation information for Autolomous is not publicly available.
Can I buy Autolomous stock?
Autolomous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Autolomous's last funding round?
Autolomous's most recent funding round was Grant on June 12, 2023.
Who are the main investors in Autolomous?
Key investors in Autolomous include UKRI Innovate UK.
Will Autolomous IPO soon?
No public IPO plans have been announced for Autolomous.
How can I track Autolomous secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Autolomous's secondary market activity and sign up for updates.